Signature Equity Partners’s Tandem Diabetes Care TNDM Stock Holding History

Signature Equity Partners’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$619	Buy	+41	New	+$716	﹤0.01%	1403

Other funds holding TNDM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

Signature Equity Partners's TNDM Position: Q2 2026 in Review

Signature Equity Partners opened a new position in Tandem Diabetes Care (TNDM) in Q2 2026: 41 shares worth $619. The stake represents ﹤0.01% of the portfolio and ranks #1403 among its holdings.

274 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.

Signature Equity Partners held 41 shares of Tandem Diabetes Care worth $619 as of Q2 2026.
Tandem Diabetes Care was a new Signature Equity Partners position in Q2 2026.
Tandem Diabetes Care made up ﹤0.01% of Signature Equity Partners's portfolio in Q2 2026, its #1403 holding.
274 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.

Based on Signature Equity Partners's 13F filing for Q2 2026, filed 30 Jul 2026.